Novo Nordisk and Viatris have agreed to resolve a patent dispute over Novo's blockbuster weight-loss drugs Ozempic and Wegovy ...

In a major milestone the obesity rate dropped by roughly 2% between 2020 and 2023 according to the national health and ...

A new study shows semaglutide medications, such as Ozempic and Wegovy, may be effective in treating hidradenitis suppurativa ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

Novo Nordisk says Massachusetts plays a key role in its bid to expand beyond its historic focus as a diabetes and obesity ...

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...

Christine Zhou started her career as a physician and clocked nearly two decades at drugmaker Eli Lilly before joining rival Novo Nordisk in 2018, where she is now president for the China region. China ...

There’s a lot to think about when you're pregnant or trying to get pregnant. If you take Ozempic®, you’ll need to talk with ...

Regeneron, a leading biotech firm, is testing a drug called trevogrumab to preserve lean muscle while using these medications ...

The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...